Completion of Final TGA Submission Step to Approve ColoSTAT

® ®  Focus remains on preparations for market launch in late CY’22. ® of ColoSTAT on the Australian Register of Therapeutic Goods (ARTG). This marks a significant regulatory ® milestone for the Company as approval of this case would open the way to the sale of ColoSTAT for clinical use in Australia. Regulatory Approval - Australia ® TGA approval is required for Rhythm and/or its partner(s) to mar